Catenon News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

17.05.18	Correvio Pharma Corp, Formerly Cardiome Pharma Corp, Announces Stock Ticker Symbol Change to CORV (PR Newswire)
17.05.18	Correvio Pharma Corp, Formerly Cardiome Pharma Corp, Announces Stock Ticker Symbol Change to CORV (PR Newswire)
17.05.18	Correvio Announces Enrollment of First Patient in Phase 3 Study Evaluating Brinavess® in China (PR Newswire)
17.05.18	Correvio Announces Enrollment of First Patient in Phase 3 Study Evaluating Brinavess® in China (PR Newswire)
15.05.18	Correvio Reports First Quarter 2018 Financial Results (PR Newswire)
15.05.18	Correvio Reports First Quarter 2018 Financial Results (PR Newswire)
15.05.18	Correvio Pharma Corp Completes Strategic Transaction with Cipher Pharmaceuticals (PR Newswire)
15.05.18	Correvio Pharma Corp Completes Strategic Transaction with Cipher Pharmaceuticals (PR Newswire)
10.05.18	GCSEN Foundation, a Leader in Accelerating Social Entrepreneurship in Higher Education Celebrates the Diana Davis Spencer Foundation's $10M Gift to Wheaton College (PR Newswire)
10.05.18	Cardiome Announces Results From Annual and Special Meeting of Shareholders and Timing For First Quarter 2018 Financial Results Conference Call (PR Newswire)
10.05.18	Cardiome Announces Results From Annual and Special Meeting of Shareholders and Timing For First Quarter 2018 Financial Results Conference Call (PR Newswire)
26.04.18	Cardiome to Present at the Bloom Burton & Co. Healthcare Investor Conference (PR Newswire)
26.04.18	Cardiome to Present at the Bloom Burton & Co. Healthcare Investor Conference (PR Newswire)
17.04.18	Cardiome Completes Enrollment in the Post Approval Safety Study SPECTRUM Evaluating Brinavess® (PR Newswire)
17.04.18	Cardiome Completes Enrollment in the Post Approval Safety Study SPECTRUM Evaluating Brinavess® (PR Newswire)
12.04.18	Cardiome Announces Fifteen Xydalba™ and Zevtera® Abstracts at ECCMID 2018 (PR Newswire)
12.04.18	Cardiome Announces Fifteen Xydalba™ and Zevtera® Abstracts at ECCMID 2018 (PR Newswire)
07.04.18	Cardiome Announces Amendment to Term Loan Agreement with CRG-Managed Funds (PR Newswire)
07.04.18	Cardiome Announces Amendment to Term Loan Agreement with CRG-Managed Funds (PR Newswire)
02.04.18	Cardiome Highlights Partner SteadyMed's Progress Towards Trevyent NDA Resubmission (PR Newswire)
02.04.18	Cardiome Highlights Partner SteadyMed's Progress Towards Trevyent NDA Resubmission (PR Newswire)
28.03.18	Cardiome Announces Recent Insider Purchases (PR Newswire)
28.03.18	Cardiome Announces Recent Insider Purchases (PR Newswire)
22.03.18	Health Canada Accepts Cardiome's Xydalba New Drug Submission and Grants Priority Review (PR Newswire)
22.03.18	Health Canada Accepts Cardiome's Xydalba New Drug Submission and Grants Priority Review (PR Newswire)
20.03.18	Cipher Pharmaceuticals and Cardiome Pharma Announce Strategic Transaction for Canadian Business Portfolio of Cardiome (PR Newswire)
20.03.18	Cipher Pharmaceuticals and Cardiome Pharma Announce Strategic Transaction for Canadian Business Portfolio of Cardiome (PR Newswire)
20.03.18	Cipher Pharmaceuticals and Cardiome Pharma Announce Strategic Transaction for Canadian Business Portfolio of Cardiome (PR Newswire)
13.03.18	Cardiome Reports Fourth Quarter and Full Year 2017 Financial Results (PR Newswire)
13.03.18	Cardiome Reports Fourth Quarter and Full Year 2017 Financial Results (PR Newswire)
13.03.18	CannTrust(MD) Holdings Inc. étend sa présence sur le marché international par la formation d'une coentreprise au Danemark avec STENOCARE (PR Newswire)
07.03.18	IIROC Trading Resumption - AXIS (PR Newswire)
06.03.18	Cardiome to Hold Fourth Quarter and Full Year 2017 Financial Results Conference Call on March 13 (PR Newswire)
06.03.18	Cardiome to Hold Fourth Quarter and Full Year 2017 Financial Results Conference Call on March 13 (PR Newswire)
05.03.18	ServerCube Launches ICO to Build the Largest Decentralized High-Capacity Computing Network for Crypto-Mining, Deep-Learning AI, VR Modeling and BaaS (PR Newswire)
13.02.18	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2017 (PR Newswire)
08.02.18	Cardiome to Present at the Leerink Partners 7th Annual Global Healthcare Conference (PR Newswire)
08.02.18	Cardiome to Present at the Leerink Partners 7th Annual Global Healthcare Conference (PR Newswire)
23.01.18	Republic Live, producteur du festival de musique Boots and Hearts, embauche une acheteuse de spectacles à l'interne (PR Newswire)
23.01.18	Cardiome Announces Expanded Label for Aggrastat® in China Including New STEMI Indication and High Dose Bolus Regimen (PR Newswire)
23.01.18	Cardiome Announces Expanded Label for Aggrastat® in China Including New STEMI Indication and High Dose Bolus Regimen (PR Newswire)
16.01.18	/R E P R I S E -- Invitation aux médias - Annonce d'un investissement pour consolider le financement d'organismes d'action communautaire autonomes dans la région de l'Abitibi-Témiscamingue/ (PR Newswire)
10.01.18	Cardiome to Participate in the Cantor Fitzgerald Antibiotics Summit (PR Newswire)
10.01.18	Cardiome to Participate in the Cantor Fitzgerald Antibiotics Summit (PR Newswire)
12.12.17	Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In Russia (PR Newswire)
12.12.17	Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In Russia (PR Newswire)
11.12.17	Cardiome Highlights Partner SteadyMed's Agreement With FDA On Pathway To Trevyent NDA Resubmission (PR Newswire)
11.12.17	Cardiome Highlights Partner SteadyMed's Agreement With FDA On Pathway To Trevyent NDA Resubmission (PR Newswire)
08.12.17	SNC-Lavalin se voit octroyer le contrat pour le projet WestConnex M4 (PR Newswire)
06.12.17	Alternate Health To Provide Investor Update And Live Q&A On December 7th Via VirtualInvestorConferences.com (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Catenon SA Bearer Shs

Aktien Top/Flop

Meistgelesene Nachrichten